华测检测 reported revenue of ¥3.43B for the period ended 2026-06-30, +15.9% year on year. Net income was ¥0.57B, a 16.6% net margin on a 49.4% gross margin. The largest revenue line is 生命科学 at 42% of the total. Free cash flow for the period was ¥0.21B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥3.43B | +15.9% |
| Gross profit | ¥1.69B | — |
| Operating income | ¥0.65B | — |
| Net income | ¥0.57B | +22.3% |
| Gross margin | 49.4% | Net margin 16.6% |
| Revenue Q/Q | +29.4% | — |
| Segment | Revenue | Share |
|---|---|---|
| 生命科学 | ¥1.43B | 41.7% |
| 工业测试 | ¥0.71B | 20.8% |
| 消费品测试 | ¥0.59B | 17.2% |
| 贸易保障 | ¥0.48B | 14.0% |
| 医药及医学服务 | ¥0.22B | 6.3% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.74B | 50.6% |
| R&D | ¥0.28B | 8.3% |
| SG&A | ¥0.76B | 22.1% |
| Tax & other | ¥0.08B | 2.2% |
| Item | Amount |
|---|---|
| Total assets | ¥10.66B |
| Total liabilities | ¥2.34B |
| Shareholders' equity | ¥8.31B |
| Equity / assets | 78.0% |
| Operating cash flow | ¥0.44B |
| Capital expenditure | ¥0.23B |
| Free cash flow | ¥0.21B |
| Cash conversion (OCF / net income) | 77% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
新宁物流 ・ 北陆药业 ・ 网宿科技 ・ 中元股份 ・ 硅宝科技 ・ ST银江 ・ 大禹节水 ・ 吉峰科技 ・ 机器人 ・ 华星创业 ・ 红日药业 ・ ST华谊
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies